1. Home
  2. VIR
  3. VIR News

Latest Vir Biotechnology Inc. (VIR) News on November 24, 2024

Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program
VIR

Business Wire

5 days ago

Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program

Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency
VIR

Business Wire

5 days ago

Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency

What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday?
VIR

Benzinga

8 days ago

What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday?

Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at AASLD The Liver Meeting
VIR

Business Wire

8 days ago

Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at AASLD The Liver Meeting

VIR

Argus Research

11 days ago

VIR: Lowering target price to $7.00

VIR

Argus Research

18 days ago

VIR: Rating decreased to a SELL

Analysts Have Lowered Expectations For Vir Biotechnology, Inc. (NASDAQ:VIR) After Its Latest Results
VIR

Simply Wall St.

20 days ago

Analysts Have Lowered Expectations For Vir Biotechnology, Inc. (NASDAQ:VIR) After Its Latest Results

Vir Biotechnology Third Quarter 2024 Earnings: Misses Expectations
VIR

Simply Wall St.

21 days ago

Vir Biotechnology Third Quarter 2024 Earnings: Misses Expectations

Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ...
VIR

GuruFocus.com

22 days ago

Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ...

Vir Biotechnology (NASDAQ:VIR) shareholders have endured a 76% loss from investing in the stock three years ago
VIR

Simply Wall St.

23 days ago

Vir Biotechnology (NASDAQ:VIR) shareholders have endured a 76% loss from investing in the stock three years ago

U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners
VIR

The Wall Street Journal

23 days ago

U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners

Vir Biotechnology, Inc. (VIR) Reports Q3 Loss, Lags Revenue Estimates
VIR

Zacks

23 days ago

Vir Biotechnology, Inc. (VIR) Reports Q3 Loss, Lags Revenue Estimates

Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
VIR

Business Wire

23 days ago

Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

State Street Corp's Strategic Acquisition in Vir Biotechnology Inc
VIR

GuruFocus.com

a month ago

State Street Corp's Strategic Acquisition in Vir Biotechnology Inc

Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024
VIR

Business Wire

a month ago

Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024

Vir Biotechnology Announces Clinical Advances Across Hepatitis Delta and Hepatitis B Programs at AASLD’s The Liver Meeting® 2024
VIR

Business Wire

a month ago

Vir Biotechnology Announces Clinical Advances Across Hepatitis Delta and Hepatitis B Programs at AASLD’s The Liver Meeting® 2024

VIR

Argus Research

2 months ago

VIR: What does Argus have to say about VIR?

Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company
VIR

Simply Wall St.

2 months ago

Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company

Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference
VIR

Business Wire

2 months ago

Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference

Vir Biotechnology Appoints Jason O’Byrne as Chief Financial Officer
VIR

Business Wire

2 months ago

Vir Biotechnology Appoints Jason O’Byrne as Chief Financial Officer

Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers
VIR

Business Wire

2 months ago

Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers

VIR

Argus Research

3 months ago

VIR: What does Argus have to say about VIR?

Vir Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
VIR

Business Wire

3 months ago

Vir Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

VIR

Argus Research

3 months ago

VIR: Raising target price to $9.00

Wall Street Analysts See a 258.38% Upside in Vir Biotechnology (VIR): Can the Stock Really Move This High?
VIR

Zacks

4 months ago

Wall Street Analysts See a 258.38% Upside in Vir Biotechnology (VIR): Can the Stock Really Move This High?

Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates
VIR

Zacks

4 months ago

Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates

Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities
VIR

Business Wire

4 months ago

Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities

Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers
VIR

Business Wire

4 months ago

Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers

VIR

Argus Research

4 months ago

VIR: What does Argus have to say about VIR?

Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024
VIR

Business Wire

4 months ago

Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024

VIR

Argus Research

4 months ago

VIR: Raising target price to $11.00

VIR

Argus Research

4 months ago

VIR: Rating increased to a HOLD

VIR

Argus Research

5 months ago

VIR: What does Argus have to say about VIR?

Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection
VIR

Business Wire

5 months ago

Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection

Is Vir Biotechnology (NASDAQ:VIR) In A Good Position To Deliver On Growth Plans?
VIR

Simply Wall St.

5 months ago

Is Vir Biotechnology (NASDAQ:VIR) In A Good Position To Deliver On Growth Plans?

Vir Biotechnology (VIR) Up on Positive Data From HDV Study
VIR

Zacks

6 months ago

Vir Biotechnology (VIR) Up on Positive Data From HDV Study

Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday?
VIR

Benzinga

6 months ago

Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday?

Tobevibart Monotherapy and Combination Therapy with Elebsiran Achieved High Virologic Response and ALT Normalization in People Living with the Hepatitis Delta Virus After 12 and 24 Weeks of Treatment
VIR

Business Wire

6 months ago

Tobevibart Monotherapy and Combination Therapy with Elebsiran Achieved High Virologic Response and ALT Normalization in People Living with the Hepatitis Delta Virus After 12 and 24 Weeks of Treatment

Vir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
VIR

Business Wire

6 months ago

Vir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer
VIR

Business Wire

6 months ago

Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer

Vir Biotechnology to Host 2024 Annual Meeting of Stockholders
VIR

Business Wire

6 months ago

Vir Biotechnology to Host 2024 Annual Meeting of Stockholders

Multiple Abstracts Highlighting Vir Biotechnology’s Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024
VIR

Business Wire

6 months ago

Multiple Abstracts Highlighting Vir Biotechnology’s Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024

Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024
VIR

Business Wire

6 months ago

Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024

Analysts Just Shipped A Stunning Upgrade To Their Vir Biotechnology, Inc. (NASDAQ:VIR) Estimates
VIR

Simply Wall St.

7 months ago

Analysts Just Shipped A Stunning Upgrade To Their Vir Biotechnology, Inc. (NASDAQ:VIR) Estimates

Wall Street Analysts Think Vir Biotechnology (VIR) Could Surge 188.65%: Read This Before Placing a Bet
VIR

Zacks

7 months ago

Wall Street Analysts Think Vir Biotechnology (VIR) Could Surge 188.65%: Read This Before Placing a Bet

Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript
VIR

Insider Monkey

7 months ago

Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript

VIR

Thomson Reuters StreetEvents

7 months ago

Q1 2024 Vir Biotechnology Inc Earnings Call

VIR

GuruFocus.com

7 months ago

Vir Biotechnology Inc (VIR) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
VIR

Zacks

7 months ago

Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
VIR

Business Wire

7 months ago

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results

Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
VIR

Business Wire

7 months ago

Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024

With 53% ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) boasts of strong institutional backing
VIR

Simply Wall St.

7 months ago

With 53% ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) boasts of strong institutional backing

What Makes Vir Biotechnology (VIR) a New Buy Stock
VIR

Zacks

7 months ago

What Makes Vir Biotechnology (VIR) a New Buy Stock

VIR

Argus Research

7 months ago

VIR: What does Argus have to say about VIR?

Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors
VIR

Business Wire

7 months ago

Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors

Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024
VIR

Business Wire

7 months ago

Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024

Vir Biotechnology Inc CEO Backer De Sells 72,995 Shares
VIR

GuruFocus.com

8 months ago

Vir Biotechnology Inc CEO Backer De Sells 72,995 Shares

Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
VIR

Business Wire

9 months ago

Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule

VIR

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Vir Biotechnology Inc Earnings Call

Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript
VIR

Insider Monkey

9 months ago

Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript

Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 186.41%: Here's is How to Trade
VIR

Zacks

9 months ago

Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 186.41%: Here's is How to Trade

Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
VIR

Business Wire

9 months ago

Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences

Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates
VIR

Zacks

9 months ago

Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
VIR

Business Wire

9 months ago

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer
VIR

Business Wire

9 months ago

Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer

3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
VIR

InvestorPlace

9 months ago

3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave

Vir Biotechnology, Inc. (NASDAQ:VIR) Analysts Just Trimmed Their Revenue Forecasts By 11%
VIR

Simply Wall St.

10 months ago

Vir Biotechnology, Inc. (NASDAQ:VIR) Analysts Just Trimmed Their Revenue Forecasts By 11%

Here's Why Rockwell Automation Stock Fell This Week
VIR

Motley Fool

10 months ago

Here's Why Rockwell Automation Stock Fell This Week

Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
VIR

Business Wire

10 months ago

Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024

CarGurus Partners with Chase to Expand Consumer Financing Options
VIR

GlobeNewswire

10 months ago

CarGurus Partners with Chase to Expand Consumer Financing Options

Forget Upstart Stock: 2 Stocks to Buy Hand Over Fist Instead
VIR

Motley Fool

10 months ago

Forget Upstart Stock: 2 Stocks to Buy Hand Over Fist Instead

Marten Transport Ltd (MRTN) Faces Headwinds as Q4 Earnings Dip
VIR

GuruFocus.com

10 months ago

Marten Transport Ltd (MRTN) Faces Headwinds as Q4 Earnings Dip

Marten Transport Announces Fourth Quarter and Year End Results
VIR

GlobeNewswire

10 months ago

Marten Transport Announces Fourth Quarter and Year End Results

Eastman Chemical (EMN) Reports Next Week: Wall Street Expects Earnings Growth
VIR

Zacks

10 months ago

Eastman Chemical (EMN) Reports Next Week: Wall Street Expects Earnings Growth

Xerox Holdings Corp (XRX) Navigates Market Challenges with Strategic Focus
VIR

GuruFocus.com

10 months ago

Xerox Holdings Corp (XRX) Navigates Market Challenges with Strategic Focus

Talos Energy Announces Upsized Proposed Offering of $1,250 Million of Second-Priority Senior Secured Notes
VIR

PR Newswire

10 months ago

Talos Energy Announces Upsized Proposed Offering of $1,250 Million of Second-Priority Senior Secured Notes

AbCellera to Report Full Year 2023 Financial Results on February 20, 2024
VIR

Business Wire

10 months ago

AbCellera to Report Full Year 2023 Financial Results on February 20, 2024

Down 96% From Its Peak, Will Peloton Stock Finally Rebound This Year?
VIR

Motley Fool

10 months ago

Down 96% From Its Peak, Will Peloton Stock Finally Rebound This Year?

16 Most Profitable New Stocks Today
VIR

Insider Monkey

10 months ago

16 Most Profitable New Stocks Today

Yielding 17.5%, Is This Dividend Stock Safe for Passive Income Investors?
VIR

Motley Fool

10 months ago

Yielding 17.5%, Is This Dividend Stock Safe for Passive Income Investors?

Is Now An Opportune Moment To Examine Liberty Latin America Ltd. (NASDAQ:LILA)?
VIR

Simply Wall St.

10 months ago

Is Now An Opportune Moment To Examine Liberty Latin America Ltd. (NASDAQ:LILA)?

California Water Service Group Opens 11th Annual College Scholarship Program Offering $80,000 in Awards
VIR

GlobeNewswire

10 months ago

California Water Service Group Opens 11th Annual College Scholarship Program Offering $80,000 in Awards

American Home Shield Offering U.S. Military Veterans Steep Discount on Home Warranty Plans
VIR

Business Wire

10 months ago

American Home Shield Offering U.S. Military Veterans Steep Discount on Home Warranty Plans

Patrick (PATK) to Buy Sportech, Expand Outdoor Enthusiast Space
VIR

Zacks

10 months ago

Patrick (PATK) to Buy Sportech, Expand Outdoor Enthusiast Space

Newell (NWL) Poised for Growth, Unveils Strategic Realignment
VIR

Zacks

10 months ago

Newell (NWL) Poised for Growth, Unveils Strategic Realignment

Is Ahold (ADRNY) Stock Undervalued Right Now?
VIR

Zacks

10 months ago

Is Ahold (ADRNY) Stock Undervalued Right Now?

Renasant Announces 2023 Fourth Quarter Webcast and Conference Call Information
VIR

GlobeNewswire

10 months ago

Renasant Announces 2023 Fourth Quarter Webcast and Conference Call Information

Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals
VIR

Business Wire

a year ago

Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals

United States Lime & Minerals, Inc. (NASDAQ:USLM) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
VIR

Simply Wall St.

a year ago

United States Lime & Minerals, Inc. (NASDAQ:USLM) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Regeneron (REGN) Surges 3.0%: Is This an Indication of Further Gains?
VIR

Zacks

a year ago

Regeneron (REGN) Surges 3.0%: Is This an Indication of Further Gains?

Why Liberty Latin America Ltd. (LILA) Has an Undervalued Rating?
VIR

Insider Monkey

a year ago

Why Liberty Latin America Ltd. (LILA) Has an Undervalued Rating?

HighPeak Energy Chairman & CEO Acquires 3.4% More Stock
VIR

Simply Wall St.

a year ago

HighPeak Energy Chairman & CEO Acquires 3.4% More Stock

John Wiley & Sons (NYSE:WLY) Is Paying Out A Dividend Of $0.35
VIR

Simply Wall St.

a year ago

John Wiley & Sons (NYSE:WLY) Is Paying Out A Dividend Of $0.35

Brookfield Business Partners L.P. 2023 Fourth Quarter Conference Call and Webcast for Investors and Analysts
VIR

GlobeNewswire

a year ago

Brookfield Business Partners L.P. 2023 Fourth Quarter Conference Call and Webcast for Investors and Analysts

Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation
VIR

Business Wire

a year ago

Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation

VIR

PR Newswire

a year ago

Vermilion Energy Inc. Announces 2024 Budget, Updated Return of Capital Framework and 20% Dividend Increase

Dorman introduces hundreds of new products, including more aftermarket exclusives and Dorman® OE FIX™ repair solutions
VIR

GlobeNewswire

a year ago

Dorman introduces hundreds of new products, including more aftermarket exclusives and Dorman® OE FIX™ repair solutions

Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
VIR

Business Wire

a year ago

Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference

The Zacks Analyst Blog Highlights United Bankshares, Wintrust Financial, First BanCorp, TowneBank and WSFS Financial
VIR

Zacks

a year ago

The Zacks Analyst Blog Highlights United Bankshares, Wintrust Financial, First BanCorp, TowneBank and WSFS Financial

5 Top-Ranked Banks That Outperformed S&P 500 in November
VIR

Zacks

a year ago

5 Top-Ranked Banks That Outperformed S&P 500 in November

Share on Social Networks: